Author:
Patterson Scott D.,Jones Byron,Zariffa Névine
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Drug guides,Pharmacology (nursing)
Reference13 articles.
1. Fitzgerald G. Coxibs and cardiovascular disease. N Engl J Med. 2004;351:1709–1711.
2. Topol E. Failing the public health—refocoxib, Merck, and the FDA. N Engl J Med. 2004;351:1707–17093.
3. International Conference on Harmonisation Draft Consensus Guideline, Step 1. The Clinical Evaluation of QT/QTc Interval Prolongation and Proarrythmic Potential for Non-Antiarrythmic Drugs. 2005. Available at: https://doi.org/www.fda.gov/cder/guidance
4. Jones B. Kenward MG. Design and Analysis of Cross-over Trials, 2nd ed. London: Chapman and Hall, CRC Press; 2003.
5. Statistical Analysis Software, SAS/STAT User’s Guide, Version 8. Cary, NC: SAS Institute: 1999.
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献